These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32826483)
1. Paliperidone-Related Sudden Elevation of Plasma D-Dimer Levels: A Case Report. Wu C; Lai J; Ma S; Huang M; Hu S; Xu Y J Clin Psychopharmacol; 2020; 40(5):506-507. PubMed ID: 32826483 [No Abstract] [Full Text] [Related]
2. Paroxysmal perceptual alteration in a schizophrenic patient treated with paliperidone: A case report. Benna P; Rubino E; Marino C; Montalenti E; Giovanna Caprioli M; Rainero I; Pinessi L Ann Clin Psychiatry; 2015 Aug; 27(3):223-4. PubMed ID: 26247222 [No Abstract] [Full Text] [Related]
3. Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia. Rossenu S; Cleton A; Hough D; Crauwels H; Vandebosch A; Berwaerts J; Eerdekens M; Herben V; De Meulder M; Remmerie B; Francetic I Clin Pharmacol Drug Dev; 2015 Jul; 4(4):270-8. PubMed ID: 27136907 [TBL] [Abstract][Full Text] [Related]
4. Clozapine, a controversial gold standard antipsychotic for the 21st century: Switching to paliperidone palmitate 3-monthly improves the metabolic profile and lowers antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort. Martínez-Andrés JA; García-Carmona JA Schizophr Res; 2019 Oct; 212():234-236. PubMed ID: 31421972 [No Abstract] [Full Text] [Related]
5. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report. Langley-DeGroot M; Joshi Y; Lehman D; Rao S J Clin Psychopharmacol; 2016 Jun; 36(3):277-9. PubMed ID: 27043124 [No Abstract] [Full Text] [Related]
6. Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration. Suzuki H; Hibino H; Inoue Y; Takaya A Asian J Psychiatr; 2018 Jun; 35():28. PubMed ID: 29751217 [No Abstract] [Full Text] [Related]
7. Hypothermia Associated With Paliperidone Depot Injection in Schizophrenia Patient: A Case Report. Hirapara K; Munir A; Aggarwal R J Clin Psychopharmacol; 2020; 40(1):86-87. PubMed ID: 31834087 [No Abstract] [Full Text] [Related]
8. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Özdemir AK; Pak ŞC; Canan F; Geçici Ö; Kuloğlu M; Gücer MK Arch Womens Ment Health; 2015 Oct; 18(5):739-40. PubMed ID: 25599999 [TBL] [Abstract][Full Text] [Related]
9. Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence. Si T; Li N; Lu H; Cai S; Zhuo J; Correll CU; Zhang L; Feng Y J Psychopharmacol; 2018 Jun; 32(6):691-701. PubMed ID: 29764266 [TBL] [Abstract][Full Text] [Related]
10. A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic. Lai JK; Margolese HC Schizophr Res; 2019 Feb; 204():443-444. PubMed ID: 30241989 [No Abstract] [Full Text] [Related]
11. Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report. Mirza H; Harding D; Al-Balushi N Sultan Qaboos Univ Med J; 2018 May; 18(2):e208-e210. PubMed ID: 30210852 [TBL] [Abstract][Full Text] [Related]
12. Two long-acting injectable antipsychotics for schizophrenia. Med Lett Drugs Ther; 2015 Nov; 57(1481):152-3. PubMed ID: 26529133 [No Abstract] [Full Text] [Related]
14. Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks. Cohen JY; Dumoulin-Charette A; Meraabi N; Poirier R Psychopharmacol Bull; 2019 Jun; 49(2):57-62. PubMed ID: 31308584 [TBL] [Abstract][Full Text] [Related]
15. Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state. Kerbusch-Herben V; Cleton A; Berwaerts J; Vandebosch A; Remmerie B Clin Pharmacol Drug Dev; 2014 Sep; 3(5):371-7. PubMed ID: 27129010 [TBL] [Abstract][Full Text] [Related]
16. A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients. Huang M; Yu L; Pan F; Lu S; Hu S; Hu J; Chen J; Jin P; Qi H; Xu Y Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():122-130. PubMed ID: 29097257 [TBL] [Abstract][Full Text] [Related]
17. Benefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia. Levitan B; Markowitz M; Turkoz I; Fu DJ; Gopal S; Alphs L Int Clin Psychopharmacol; 2016 Nov; 31(6):315-22. PubMed ID: 27434314 [TBL] [Abstract][Full Text] [Related]
18. A retrospective observational study of the effectiveness of paliperidone palmitate on acute inpatient hospitalization rates. Bressington D; Stock J; Hulbert S; MacInnes D Int Clin Psychopharmacol; 2015 Jul; 30(4):230-6. PubMed ID: 25882381 [TBL] [Abstract][Full Text] [Related]